Literature DB >> 11087234

Renin-angiotensin system and sympathetic nervous system in cardiac pressure-overload hypertrophy.

W S Akers1, A Cross, R Speth, L P Dwoskin, L A Cassis.   

Abstract

Angiotensin II and norepinephrine (NE) have been implicated in the neurohumoral response to pressure overload and the development of left ventricular hypertrophy. The purpose of this study was to determine the temporal sequence for activation of the renin-angiotensin and sympathetic nervous systems in the rat after 3-60 days of pressure overload induced by aortic constriction. Initially on pressure overload, there was transient activation of the systemic renin-angiotensin system coinciding with the appearance of left ventricular hypertrophy (day 3). At day 10, there was a marked increase in AT(1) receptor density in the left ventricle, increased plasma NE concentration, and elevated cardiac epinephrine content. Moreover, the inotropic response to isoproterenol was reduced in the isolated, perfused heart at 10 days of pressure overload. The affinity of the beta(2)-adrenergic receptor in the left ventricle was decreased at 60 days. Despite these alterations, there was no decline in resting left ventricular function, beta-adrenergic receptor density, or the relative distribution of beta(1)- and beta(2)-receptor sites in the left ventricle over 60 days of pressure overload. Thus activation of the renin-angiotensin system is an early response to pressure overload and may contribute to the initial development of cardiac hypertrophy and sympathetic activation in the compensated heart.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087234     DOI: 10.1152/ajpheart.2000.279.6.H2797

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  13 in total

1.  Circumferential wall tension due to hypertension plays a pivotal role in aorta remodelling.

Authors:  Cibele M Prado; Marcos A Rossi
Journal:  Int J Exp Pathol       Date:  2006-12       Impact factor: 1.925

2.  Angiotensin II potentiates adrenergic and muscarinic modulation of guinea pig intracardiac neurons.

Authors:  Allison E Girasole; Christopher P Palmer; Samantha L Corrado; E Marie Southerland; Jeffrey L Ardell; Jean C Hardwick
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-24       Impact factor: 3.619

Review 3.  Modulation of the QT interval duration in hypertension with antihypertensive treatment.

Authors:  Jan Klimas; Peter Kruzliak; Simon W Rabkin
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

4.  Use of renin-angiotensin inhibitors in people with renal artery stenosis.

Authors:  Kaleigh L Evans; Katherine R Tuttle; David A Folt; Taylor Dawson; Steven T Haller; Pamela S Brewster; Wencan He; Kenneth Jamerson; Lance D Dworkin; Donald E Cutlip; Timothy P Murphy; Ralph B D'Agostino; William Henrich; Christopher J Cooper
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 8.237

5.  Peptide-based inhibition of NF-κB rescues diaphragm muscle contractile dysfunction in a murine model of Duchenne muscular dystrophy.

Authors:  Jennifer M Peterson; William Kline; Benjamin D Canan; Daniel J Ricca; Brian Kaspar; Dawn A Delfín; Kelly DiRienzo; Paula R Clemens; Paul D Robbins; Albert S Baldwin; Pat Flood; Pravin Kaumaya; Michael Freitas; Joe N Kornegay; Jerry R Mendell; Jill A Rafael-Fortney; Denis C Guttridge; Paul M L Janssen
Journal:  Mol Med       Date:  2011-01-20       Impact factor: 6.354

6.  Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice.

Authors:  Li-qing Weng; Wen-bin Zhang; Yong Ye; Pei-pei Yin; Jie Yuan; Xing-xu Wang; Le Kang; Sha-sha Jiang; Jie-yun You; Jian Wu; Hui Gong; Jun-bo Ge; Yun-zeng Zou
Journal:  Acta Pharmacol Sin       Date:  2014-07-07       Impact factor: 6.150

7.  Involvement of chymase-mediated angiotensin II generation in blood pressure regulation.

Authors:  Ming Li; Ke Liu; Jan Michalicek; James A Angus; John E Hunt; Louis J Dell'Italia; Michael P Feneley; Robert M Graham; Ahsan Husain
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 8.  Cardiovascular morbidity and mortality and renal artery stenosis.

Authors:  William R Colyer; Christopher J Cooper
Journal:  Prog Cardiovasc Dis       Date:  2009 Nov-Dec       Impact factor: 8.194

9.  Adaptations to iron deficiency: cardiac functional responsiveness to norepinephrine, arterial remodeling, and the effect of beta-blockade on cardiac hypertrophy.

Authors:  Lexa Rae Turner; Daniel Aaron Premo; Brett Jason Gibbs; Megan Lesley Hearthway; Madelyne Motsko; Andrea Sappington; LeeAnn Walker; Michael Eugene Mullendore; Herbert George Chew
Journal:  BMC Physiol       Date:  2002-01-09

10.  Early dystrophin loss is coincident with the transition of compensated cardiac hypertrophy to heart failure.

Authors:  Fernanda P Prado; Daniele O Dos Santos; Valdecir Blefari; Carlos A Silva; Juliano Machado; Isis do Carmo Kettelhut; Simone G Ramos; Marcelo Dias Baruffi; Helio C Salgado; Cibele M Prado
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.